Report

The global infertility treatment devices market was valued at USD 2.09 Billion in 2024, driven by the increasing adoption of advanced reproductive technologies and innovative healthcare solutions across the globe. It is expected to grow at a CAGR of 5.78% during the forecast period of 2025-2034, with the values likely to reach USD 3.67 Billion by 2034.

Infertility Treatment Devices Market Overview

Infertility treatment devices include advanced tools like incubators, microscopes, and injectables that assist in addressing fertility challenges. The demand for infertility treatment devices is primarily driven by the rising infertility rates due to lifestyle changes, stress, and pollution. Trends like AI integration and advancements in microscopy technology are enhancing treatment precision and outcomes. These factors, combined with growing awareness and regulatory approvals, are propelling market growth as healthcare providers increasingly adopt cutting-edge devices to meet the rising demand for effective infertility treatments.

Infertility Treatment Devices Market Growth Drivers

Rising Prevalence of Infertility Rates Drives Market Growth

Infertility rates are rising globally due to modern lifestyle factors such as stress, unhealthy diets, lack of physical activities, and delays in parenthood. Environmental factors like pollution and exposure to harmful chemicals are also significant contributors. According to the World Health Organization (WHO) 2023 data, around 17.7% of the adult population approximately 1 in 6 worldwide experienced infertility, highlighting the need for affordable, high-quality fertility care. �This increasing prevalence has underscored the urgency for innovations in infertility treatment devices. Advanced technologies and personalized solutions are being developed to address these challenges and provide effective support to individuals facing infertility.

Integration of Artificial Intelligence and Machine Learning to Meet Increasing Infertility Treatment Devices Market Demand

Artificial intelligence (AI) and machine learning are transforming various medical domains, including infertility treatments. AI significantly enhances embryo selection accuracy and forecasts treatment outcomes. By employing sophisticated algorithms, it can examine extensive data from past in-vitro fertilization (IVF) cycles to uncover patterns, helping identify the most viable embryos for transfer. This approach boosts IVF success rates while minimizing the time and expenses linked to repeated treatment attempts. Additionally, AI improves sperm analysis by offering objective assessments of sperm quality, surpassing traditional methods that are often influenced by human error, people are turning to AI and machines for personalized solutions, speed, and precision. These advancements are significantly boosting the growth of the market.

Infertility Treatment Devices Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Advancements in Microscopy Technology to Propel Market Growth

Microscopy technologies are shaping the market by improving workflow efficiency and accuracy, making them essential for modern infertility treatments. These technologies are gaining traction in the market as they address growing demands for precision and innovation in reproductive healthcare. For instance, in July 2024, Nikon launched the ECLIPSE Ti2-I Motorized Inverted Microscope, designed to streamline ICSI and IMSI workflows in reproductive medicine. The microscope reduced operational steps by approximately 75%, improving efficiency and accuracy in infertility treatments. Its intuitive design featured a touch screen and enhanced optical technology, allowing precise observation of eggs and sperm, including spindle structures. Such innovations address the emphasis on managing the growing workload of embryologists while enhancing micro-insemination accuracy, marking a significant advancement in microscopy technology and boosting market growth.

Launch of Generic Injectables to Propel the Infertility Treatment Devices Market Value

Injectables are being used in infertility treatment as they offer improved treatment outcomes. Their effectiveness and convenience are encouraging more people to opt for these solutions. This growing preference is driving their adoption in the market, making injectables a key component in modern infertility treatment practices. For instance, in February 2024, Lupin launched Ganirelix Acetate Injection, its first peptide-based injectable in the United States after receiving FDA approval. This single-dose prefilled syringe is a generic equivalent of Organon USA's Ganirelix Acetate Injection and is designed to inhibit premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. This launch strengthened Lupin's presence in women's health and highlighted its commitment to innovative healthcare solutions in the global market.

Establishment of Specialized Training Centres to Drive Infertility Treatment Devices Market Growth

Training centres provide advanced facilities, hands-on training, and access to the latest technologies, ensuring precision in infertility treatments. These centres are playing a vital role in the market by enhancing the skills of researchers and practitioners. With the growing demand for improved success rates, people are increasingly relying on these centres to access cutting-edge expertise and better treatment outcomes. For instance, in May 2024, CHA Medical Group opened Korea's first global infertility training center at the CHA Bio Complex in Gyeonggi Province. The center addressed the lack of specialized training facilities for infertility researchers in Korea. Equipped with advanced technology, the facility provided theoretical and practical training in techniques such as ICSI and embryo biopsy. This initiative aimed to improve researcher skills, enhance pregnancy success rates, and attract domestic and international participants, marking a significant step in advancing infertility treatment standards.

Surge in Regulatory Approvals to Augment the Infertility Treatment Devices Market Size

The market is witnessing a rise in regulatory approvals to meet the growing demand for effective and affordable options. As authorities continue to prioritize patient safety and innovation, devices gaining approval are transforming how infertility treatments are delivered. For instance, in December 2023, the FDA granted clearance to the PherDal Kit, the first sterile at-home insemination kit in the United States. The PherDal Kit was officially launched in October 2024, marking a significant regulatory milestone and expanding accessibility to safe, affordable infertility treatment options in the market.

Infertility Treatment Devices Market Segmentation

Infertility Treatment Devices Market Report and Forecast 2025-2034" offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

- Sperm Separation Devices
- Ovum Aspiration Pumps
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Imaging Systems
- Microscopes
- Others

Market Breakup by Patient Type

- Male
- Female

Market Breakup by End User

- Fertility Clinics
- Hospitals and Surgical Clinics
- Research Institutes
- Others

Market Breakup by Distribution Channel

- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others

Market Breakup by Region

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa

Infertility Treatment Devices Market Share

Female Patient is Projected to Hold the Substantial Market Share

Based on the patient type, the market is divided into males and females. Among these, the female patient segment is expected to lead the market due to several factors. Women typically engage more with healthcare services, often seeking preventive care, reproductive health services, and chronic disease management, which are influenced by hormonal changes and life stages. Additionally, changing lifestyles such as increased alcohol consumption and smoking raise concerns about infertility, making targeted healthcare solutions even more critical. The rise of targeted treatments addressing female-specific health concerns and increased awareness around women's health issues have led to expanded service offerings in the market. As the global population ages and the prevalence of chronic conditions rises, health engagement and spending on and by females is likely to grow significantly. This will drive innovation and investment in therapies and products, tailored to meet their unique needs. This increased focus on female health, combined with the evolving lifestyle factors affecting women's health, is poised to propel substantial growth in the market over the forecast period.

Infertility Treatment Devices Market Segmentation by End User to Witness Significant Growth

Based on the end users, the market is segmented into fertility clinics, hospitals and surgical clinics, research institutes, and others. Among these, fertility clinics are expected to lead the market due to the rising global prevalence of infertility and the growing awareness of advanced reproductive technologies (ART). As societal attitudes shift towards delaying parenthood and lifestyle factors impact fertility rates, more individuals and couples are turning to specialized services offered by fertility clinics, which provide comprehensive care tailored to their unique needs. Moreover, advancements in techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) have enhanced success rates, further attracting patients to these clinics. The increasing demand for personalized treatment plans and support services will drive significant growth in this segment, positioning fertility clinics as a key pillar of the reproductive health market in the forecast period.

Infertility Treatment Devices Market Analysis by Region

Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among these, North America is expected to dominate the market due to factors like high awareness of reproductive health issues, advanced healthcare infrastructure, and significant investments in research and development. The increasing prevalence of infertility, driven by factors such as delayed childbearing, lifestyle changes, and rising rates of conditions affecting fertility, has led to greater demand for innovative treatment options.

Additionally, North America boasts a large number of established fertility clinics and specialists, equipped with cutting-edge medical technologies and therapies, which contribute to higher success rates in treatments like in vitro fertilization (IVF). The supportive regulatory environment and insurance coverage for fertility treatments will also stimulate market growth in the forecast period by making these services more accessible. As public awareness continues to grow and technological advancements emerge, North America is poised to maintain its leadership in the market, driving ongoing innovation and expanding service capabilities to meet the needs of an increasingly diverse patient population.

Leading Players in the Infertility Treatment Devices Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Cook Group Incorporated

Founded in 1963, Cook Group Incorporated is headquartered in Bloomington, USA. The company offers innovative infertility treatment devices, including the MINC� Incubator, which maintains optimal conditions for embryo culture. Cook Group is known for its high-quality reproductive health solutions that support embryologists and clinics in achieving improved patient outcomes.

Esco Micro Pte Limited

Established in 1978, Esco Micro Pte Limited is based in Singapore. The company specializes in laboratory and medical equipment, including the Esco MIRI� Time-Lapse Incubator. This advanced device provides real-time monitoring of embryos, ensuring optimal conditions and improving success rates for in-vitro fertilization procedures.

Genea Limited

Genea Limited, established in 1985, is headquartered in Sydney, Australia. The company introduced the Gavi� Automated Vitrification Instrument, a device for cryopreserving embryos and eggs. This innovation enhances the efficiency and consistency of infertility treatments, supporting clinics worldwide in improving patient outcomes.

Hamilton Thorne Ltd.

Founded in 2007, Hamilton Thorne Ltd. is headquartered in Beverly, USA. The company has developed the LYKOS� Laser System, designed for precise embryo biopsy and assisted hatching. This device is widely used in infertility clinics, offering advanced solutions for improving fertility treatment success rates.

Other key players in the market include Medgyn Products Inc., Eppendorf SE, The Cooper Companies, Inc., Thermo Fisher Scientific Inc., Vitrolife AB, Rocket Medical plc, DxNow, Inc., and AB Scientific Ltd.

Key Questions Answered in the Infertility Treatment Devices Market

- What was the global infertility treatment devices market value in 2024?
- What is the global infertility treatment devices market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the type?
- What is the market breakup based on the patient type?
- What is the market segmentation based on the end user?
- What is the market breakup based on the distribution channel?
- What are the major factors aiding the infertility treatment devices market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major infertility treatment device market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the infertility treatment devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?